US Rep. Guinta Continues Fight Against NH's Heroin Epidemic


House Unanimously Passes H.R. 1725 and H.R. 1462


Washington, D.C. – Last night, the House of Representatives unanimously passed H.R. 1725, the National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 and H.R. 1462, Protecting our Infants Act of 2015. 


These pieces of legislation seek to address the issue of heroin and opioid abuse.  The first bill reauthorizes the national prescription drug monitoring program, while the second bill passed to combat the rise of prenatal opioid abuse and neonatal abstinence syndrome.


“We must continue to work toward establishing an opioid prescription drug database that will allow pharmacies to monitor the flow of these highly addictive drugs across state lines. The over-prescription of these drugs has led to the spike in heroin abuse as users continue to seek a cheaper alternative drug to the expensive street value of prescription opioid narcotics.


Toward that end, I also supported legislation that would combat the rise of prenatal opioid abuse and neonatal abstinence syndrome. With opioid prescription rates rising dramatically over the past several years, there has also been a rise of neonatal abstinence syndrome. These two pieces of important legislation play a crucial role in various aspects of the heroin abuse epidemic throughout the Granite State.”


The Congressman is currently working on his own piece of bipartisan legislation to fight against the heroin epidemic in New Hampshire.  Already this term, he has authored an amendment to increase funding for our nation’s drug courts, as well as cosponsored three pieces of bipartisan legislation aimed at tackling the heroin abuse epidemic.